glp-1 agonists and pancreatitis Glucagon-Like Peptide-1 Receptor Use... : American Journal of Gastroenterology Risk of pancreatic cancer associated
Description
Pratley RE, Aroda VR, Lingvay I, Ldemann J, Andreassen C, Navarria A, et al
It has been suggested that these drugs could act through the non-classic RAAS pathways in the context of simultaneous RAAS blockade
Whats your current dose
Agents such as pemvidutide (Harrison et al
The use of nalbuphine, a blocker of - and -opioid receptors, also disrupted the effect of GLP-1RAs on reducing TNF- levels, highlighting the essential role of these opioid receptors in the anti-inflammatory effects mediated by GLP-1RAs
